21 related articles for article (PubMed ID: 15485480)
1. Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.
; Beral V; Gaitskell K; Hermon C; Moser K; Reeves G; Peto R
Lancet Oncol; 2012 Sep; 13(9):946-56. PubMed ID: 22863523
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.
Collaborative Group on Epidemiological Studies of Ovarian Cancer
PLoS Med; 2012; 9(4):e1001200. PubMed ID: 22606070
[TBL] [Abstract][Full Text] [Related]
3. Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study.
Lindman AS; Veierød MB; Tverdal A; Pedersen JI; Selmer R
Eur J Epidemiol; 2010 Nov; 25(11):789-98. PubMed ID: 20890636
[TBL] [Abstract][Full Text] [Related]
4. Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women.
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
Scand J Public Health; 2006; 34(1):11-6. PubMed ID: 16449039
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption and cardiovascular mortality accounting for possible misclassification of intake: 11-year follow-up of the Melbourne Collaborative Cohort Study.
Harriss LR; English DR; Hopper JL; Powles J; Simpson JA; O'Dea K; Giles GG; Tonkin AM
Addiction; 2007 Oct; 102(10):1574-85. PubMed ID: 17854334
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study.
Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Hundrup YA; Obel EB; Pedersen AT
Arch Neurol; 2003 Oct; 60(10):1379-84. PubMed ID: 14568807
[TBL] [Abstract][Full Text] [Related]
8. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
[TBL] [Abstract][Full Text] [Related]
9. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.
Muka T; Oliver-Williams C; Kunutsor S; Laven JS; Fauser BC; Chowdhury R; Kavousi M; Franco OH
JAMA Cardiol; 2016 Oct; 1(7):767-776. PubMed ID: 27627190
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches.
Jeanes H; Newby D; Gray GA
Expert Opin Pharmacother; 2007 Feb; 8(3):279-88. PubMed ID: 17266463
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women.
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
J Intern Med; 2004 Nov; 256(5):437-45. PubMed ID: 15485480
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
